Protein interactions play key roles throughout all subcellular compartments. In the present paper, we report the visualization of protein interactions throughout living mammalian cells using two oligomerizing MV (measles virus) transmembrane glycoproteins, the H (haemagglutinin) and the F (fusion) glycoproteins, which mediate MV entry into permissive cells. BiFC (bimolecular fluorescence complementation) has been used to examine the dimerization of these viral glycoproteins. The H glycoprotein is a type II membrane-receptor-binding homodimeric glycoprotein and the F glycoprotein is a type I disulfide-linked membrane glycoprotein which homotrimerizes. Together they cooperate to allow the enveloped virus to enter a cell by fusing the viral and cellular membranes. We generated a pair of chimaeric H glycoproteins linked to complementary fragments of EGFP (enhanced green fluorescent protein) -haptoEGFPs -which, on association, generate fluorescence. Homodimerization of H glycoproteins specifically drives this association, leading to the generation of a fluorescent signal in the ER (endoplasmic reticulum), the Golgi and at the plasma membrane. Similarly, the generation of a pair of corresponding F glycoprotein-haptoEGFP chimaeras also produced a comparable fluorescent signal. Co-expression of H and F glycoprotein chimaeras linked to complementary haptoEGFPs led to the formation of fluorescent fusion complexes at the cell surface which retained their biological activity as evidenced by cell-to-cell fusion.
INTRODUCTION
Many techniques have been developed to both temporally and spatially interrogate protein-protein interactions. Yeast two- [1, 2] and three- [3] hybrid systems have been instrumental in identifying novel interactions, as these approaches are readily adaptable to high-throughput screens. These systems are based on the modular properties of nuclear transcription factors that are assembled following the association of interacting partners. Consequent expression of a reporter protein renders downstream protein purification and biochemical analysis unnecessary. Nevertheless, these systems are not without their drawbacks as the interacting partners must be able to traffic to the nucleus to activate the reporter gene. This is a particular problem for membrane-anchored proteins which cannot readily translocate to the nucleus and, there- Abbreviations used: AP , alkaline phosphatase; BiFC, bimolecular fluorescence complementation; CLSM, confocal laser scanning microscopy; CMV, cytomegalovirus; Cy3, indocarbocyanine; d.p.t., days post-transfection; EGFP , enhanced green fluorescent protein; ER, endoplasmic reticulum; F, fusion; GFP , green fluorescent protein; H, haemagglutinin; h.p.t., hours post-transfection; MV, measles virus; sgGFP , super green GFP; SLAM, signalling lymphocyte activation molecule. 1 To whom correspondence should be addressed (email pduprex@bu.edu) fore, is not surprising that these interactions are underrepresented in genome-wide screens [4, 5] . To overcome the limitation of classic yeast hybrid systems, a split-ubiquitin membrane yeast twohybrid system has been developed [6] . The membrane proteins to be studied are fused to two halves of ubiquitin, additionally one of the ubiquitin halves is fused to a transcription factor. When the two ubiquitin halves combine during a protein-protein interaction, ubiquitin-specific proteases cleave it thereby releasing the transcription factor which can translocate freely to the nucleus, where it brings about transcription of a reporter gene [6] .
Viruses provide excellent models to study protein-protein interactions. MV (measles virus) infection is mediated by a complex of two viral envelope glycoproteins. The H (haemagglutinin) glycoprotein binds to cellular receptors and the F (fusion) glycoprotein, which is synthesized as an inactive precursor (F 0 ), mediates fusion of the viral and target cell plasma membranes [7] . F 0 is a highly conserved type I transmembrane glycoprotein which is cleaved by furin in the trans-Golgi to yield F 1 and F 2 . These are disulfide-linked and form the fusion-active protein [8, 9] , the glycoprotein has a short cytoplasmic tail of 33 amino acids. The H glycoprotein is a type II transmembrane glycoprotein which resides on the surface of infected cells and virions as a disulfide-linked homodimer [10, 11] , the cytoplasmic tail is comprised of 34 amino acids. It folds and homodimerizes in the ER (endoplasmic reticulum) and may exist on the virion as a tetrameric dimer of dimers. Precisely where dimerization takes places in the cell and the spatial arrangement of the fusion-active F-H complexes on the cell or virion is presently unknown. A number of key cysteine residues mediating H-H glycoprotein interactions have been identified [10, 12] , and strong homotypic and heterotypic interactions of MV glycoproteins have been identified, implicating the ER as a site of MV glycoprotein complex formation [13] . Cell entry by the virus is dependent upon the interaction of the F-H glycoprotein fusion complex with either CD46 in the case of vaccine viruses [14, 15] or SLAM (signalling lymphocyte activation molecule)/CD150w in the case of wild-type isolates [16] . Other SLAM-independent routes may be important in vivo (reviewed in Yanagi et al. [17] ), but are not associated with cell fusion. Fusion is dependent on the interaction of the F-H glycoprotein complex with surface receptors and acts as a useful biological assay following mutagenesis experiments.
In the present study we have used the BiFC (bimolecular fluorescence complementation) system [18, 19] , which was initially used to investigate the interaction of proteins in the nucleus and cytoplasm. In this approach there is no detectable fluorescent signal until split EGFP [enhanced GFP (green fluorescent protein)] fragments (haptoEGFPs) are brought together due to association of the binding partners to which they are fused. It has been possible to monitor multiple simultaneous protein interactions using this technique and determine whether this occurs in the nucleoplasm or nucleolus [20] . Interactions of peripheral membrane proteins can be monitored by BiFC provided consideration is given to the position of the fusion termini with respect to the plasma membrane; for example, Hynes et al. [21] fused one of the binding partners to the authentic C-terminus and the other to the novel C -terminus of EGFP. A combination of BiFC with FRET (fluorescence resonance transfer) has also been used to monitor conformation changes in a membranebound receptor [22] . Selective development of fluorescence as a marker of protein-protein interactions in particular cells and subcellular organelles using cell-and organelle-selective promoters is also possible [23] . Recently, the interaction of a type I nonglycosylated transmembrane protein in the lumen of the ER has been reported, demonstrating that the haptoEGFPs can also be assembled in an oxidizing environment [24] .
Cells transiently co-transfected with F and H glycoprotein expression plasmids form multi-nucleated cells or syncytia which are indistinguishable from those produced by the virus [25, 26] .
In the present study, we demonstrate that complementary haptoEGFPs can be separately added to the cytoplasmic tail of the MV-F and MV-H glycoproteins and that both homologous and heterologous interaction among these species can be detected by observing an intracellular fluorescent signal upon expression in mammalian cells. Moreover, since fusion-active fluorescent complexes are formed upon co-expression of the glycoprotein chimaeras, this indicates that the addition of haptoEGFP fragments does not impede either the trafficking of the glycoproteins to the cell surface or their biological function at the membrane. Using this approach, we have confirmed the versatility of this technique for visualizing protein interactions in a variety of subcellular compartments and report the first use of BiFC to visualize both type I and II transmembrane viral glycoprotein-glycoprotein interactions and trafficking in living cells. In doing so, we prove that both MV-F and MV-H proteins homo-oligomerize and heterooligomerize with each other in the ER.
EXPERIMENTAL

Materials
All restriction enzymes were obtained from New England Biolabs. Oligonucleotides were obtained from Qiagen. The MV-F and MV-H gene sequences were obtained from an Edmonston laboratory-adapted strain of MV [27] . Other reagents were obtained from Sigma-Aldrich. MilliQ water was used throughout for preparation of solutions.
Construction of haptoEGFP expression plasmids
pEGFP-N1 (Clontech, BD Biosciences) was used as the source of the EGFP gene. The multiple cloning site between the promoter and EGFP-coding region was replaced by an oligonucleotide linker containing two unique restriction sites (PacI and SmaI). Digestion of the vector with NheI and AgeI and introduction of the compatible linker produced the construct p(NPSA)EGFP. The CMV (cytomegalovirus) immediate early promoter was retained to facilitate expression in mammalian cells. Site-directed mutagenesis was used to ablate the endogenous SfiI site (nucleotides 2525-2537) of p(NPSA)EGFP. The sequence was altered from GGCCGCCTCGGCC (nucleotides 2525-2537) of p(NPSA)EGFP to GGCCGCCTCGGCA by QuikChange ® mutagenesis (Stratagene) to generate the construct p(NPSA)EGFP SfiI C/A.
Constructs encoding haptoEGFPs linked to short hydrophilic glycine/serine spacers were generated by PCR. Sequences encoding amino acids 1-157 of EGFP were amplified using a forward primer containing an AgeI site and the first 12 nucleotides of the EGFP gene and a reverse primer containing a NotI site, and sequences encoding the reverse complement of the hydrophilic spacer (GGSGSG), two N-terminal leucine zipper residues (AL) and residues 150-157 of EGFP. Insertion of these sequences into p(NPSA)EGFP produced construct pN 157 (6) where N 157 indicates residues 1-157 of EGFP and the number in parentheses represents the length of the hydrophilic spacer. This construct was engineered to include a unique SacI site within the sequences encoding the hydrophilic spacer to allow the introduction of a gene encoding the first binding partner. was generated using a similar strategy using the p(NPSA)EGFP SfiI C/A backbone, this was named pN 157 (6) SfiI C/A. A similar approach was used to generate a plasmid encoding a spacer together with the complementary haptoEGFP (residues 158-239), and this is designated p(4)C 158 . A forward primer containing an AgeI site and sequences encoding three C-terminal residues, MVS (for optimal mammalian expression), a hydrophilic spacer (GGSG) and residues 158-164 of EGFP, was used with a reverse primer containing a NotI site and oligonucleotides encoding the reverse complement of the last seven residues of EGFP. A unique BamHI site was engineered within the oligonucleotides encoding the hydrophilic spacer of p(4)C 158 to allow the introduction of a gene encoding the second binding partner.
Construction of haptoEGFP expression plasmids containing synthetic leucine zippers
Oligonucleotide linkers encoding N-and C-terminal leucine zippers (ALKKELQANKKELAQLKWELQALKKELAQ and EQLEKKLQALEKKLAQLEWKNQALEKKLAQ respectively) [18] were inserted into SacI-and NotI-restricted pN 157 (6) Plasmids pMV-F(16)N 157 and pMV-F(14)C 158 were generated as above. Briefly, by the insertion of complementary oligonucleotides containing two SfiI sites (SfiIA and SfiIB) and an additional ten residue linker into pN 157 (6) and pC 158 (4) respectively, using BamHI and NotI, the open reading frame of the F gene of MV was inserted into both plasmids as above using SfiI to produce pMV-F(16)N 157 and pMV-F(14)C 158 . Sequences were transferred as PacI/NotI fragments into an additional mammalian expression vector pCG [28] , which was modified to include PacI, NotI and SpeI in the multiple cloning site.
Details of the PCR amplification approaches, oligonucleotide sequences, construct sequences and construct maps are available on request for all of the plasmids used in the present study ( 
Cell culture and transient transfection
Vero cells (A.T.C.C.) were cultured in 35-mm-diameter Petri dishes to a confluency of 80 % as described previously [29] . Cells were transiently transfected with plasmids (1-5 μg) using Lipofectamine TM 2000 reagent (Invitrogen), according to the manufacturer's instructions. Monolayers were observed using a Leica DIMBRE inverted microscope from 12 h.p.t. (hours post-transfection) by phase-contrast microscopy, and photomicrographs were obtained using a Leica 350DC digital camera. If necessary, cell fusion was inhibited using fusion-inhibitory peptide (Z-D-Phe-Phe-Gly; Sigma-Aldrich).
Live-cell UV and CLSM (confocal laser scanning microscopy)
Fluorescence in living cells cultured in 35-mm-diameter Petri dishes was examined at various time points after transfection using a Leica DIMBRE inverted microscope equipped with an EGFP filter block or a Leica AOBS confocal scanning laser microscope as described previously [30] .
Fluorescence quantification
Vero cells were cultured and transfected in triplicate as above. Cells were infected with a recombinant virus which expresses EGFP (MVeGFP) and these were used as a positive control [30] . Mock-transfected cells were used as a negative control. Cell monolayers were washed three times in PBS at 36 h.p.t. and cells were detached by trypsinization. Cell suspensions were washed in PBS, pelleted by centrifugation and resuspended in PBS (1 ml). Cell numbers were obtained using a haemocytometer and 800 000 cells in PBS (100 μl) were transferred to a black 96-well Greiner plate (Sigma-Aldrich) and read immediately. A Genios plate reader (Tecan) was used to determine the level of fluorescence in each well using an excitation wavelength of 485 nm and an emission wavelength of 535 nm. Fluorescence was related to a standard curve obtained using recombinant sgGFP (super green GFP; Qbiogene) and these levels are expressed in femtomoles of GFP.
Indirect immunofluorescence, CLSM and three-dimensional image reconstruction
Vero cells, grown to a confluency of 80 % on glass coverslips in 35-mm-diameter Petri dishes, were transfected as above. Cells were fixed in paraformaldehyde and EGFP fluorescence was examined by CLSM as described previously [30] . A mouse monoclonal antibody (L77) which recognizes the H glycoprotein of MV was obtained from Dr Jürgen Schneider-Schaulies (Institute of Virology, University of Würzburg, Würzburg, Germany). This primary antibody was used at a dilution of 1:1000 and bound antibody was visualized using a Cy3 (indocarbocyanine)-conjugated goat anti-mouse secondary antibody (Sigma-Aldrich) used at a dilution of 1:500. Confocal datasets were saved as tiff files and these were imported into Volocity Software (Improvision). Threedimensional surfaces were rendered, movie files were generated of the surfaces and these were stored as mpeg files.
Immunoblotting
Vero cells were transiently transfected for 2 days. Cells (800 000) were lysed by boiling in SDS/PAGE sample buffer for 5 min and the samples were passed through a hypodermic needle (five times) to shear DNA. Treated samples were separated using 10-20 % gradient tricine polyacrylamide gels (Invitrogen). Proteins were transferred on to nitrocellulose and Western blots were performed by following standard procedures. Previously, we have found that detection of both the N-and C-terminal portions of EGFP was difficult to achieve using just a single antibody (results not shown). To overcome the problem of epitope preference, we used a mixture of two antibodies for the detection of EGFP portions. Rabbit polyclonal antisera 632377 (Clontech, BD Biosciences), which was best at detecting the C-terminal portion, was used at 1:200 dilution and ab6556 (Abcam), which was best at detecting the Nterminal portion, was used at 1:10000 dilution. An AP (alkaline phosphatase)-conjugated anti-rabbit IgG (F c ) antibody (SigmaAldrich) was used as a secondary antibody at a 1:5000 dilution. Lysates from MVeGFP-infected cells were used as a positive control for EGFP expression [30] . Bound AP conjugate was detected using the FAST BCIP/NBT substrate (Sigma-Aldrich). Alternatively, for chemiluminescence detection the ECL (enhanced chemiluminescence)-Plus kit (Amersham Biosciences) was used in conjunction with a secondary HRP (horseradish peroxidase)-conjugated anti-rabbit antibody (Sigma-Aldrich). The molecular mass markers SeeBlue plus 2 (Invitrogen) were used to determine the respective molecular masses of the proteins.
RESULTS
Variation in fluorescence with haptoEGFP split point position
It was important to address two important preliminary questions before investigation of viral protein interactions was possible: first, is the commonly used split point in the short loop connecting β strands 7 and 8 optimal for fluorescence generation in the associated EGFP fragments, and secondly, how far can the interacting partners be spatially separated from the EGFP fragments without significantly decreasing fluorescence?
The three-dimensional structure of EGFP was examined and a number of split points were identified to address the first question. Initially we chose to use high-affinity leucine zippers as interacting partners [18] separated from the EGFP fragments by flexible hydrophilic spacers comprised of either four or six amino acids, as in the original procedure. Construct pairs were generated which expressed compatible N-and C-terminal hapto-EGFP fragments, followed or preceded by antiparallel leucine zippers of either 29 or 30 residues. Transfection of these constructs into mammalian cells demonstrated that a specific association occurred between non-fluorescent haptoEGFPs with split points at EGFP 157/158 and EGFP 172/173 . However, no fluorescence was detected using haptoEGFP pairs when EGFP 142/143 or EGFP 190/191 split points were used ( Figures 1A-1D ). There were significant differences in the times at which fluorescence was first detectable in transfected cells. 
Variation in fluorescence with haptoEGFP and hydrophilic linker length
In the case of many interacting proteins, the proximity of the Nand/or C-terminal fusion to which haptoEGFPs may be attached is unknown. In order to address this, we chose to increase the length of the hydrophilic spacer in N 157 (6)zip to 16, 26, 36 and 46 residues and to record any concomitant changes in fluorescence intensity. To complement this, the spacer in zip(4)C 158 was increased to 14, 24, 34 and 44 amino acids. No significant differences in the levels of fluorescence were observed when the hydrophilic spacers were lengthened by up to 26 and 24 amino acids respectively. However, the signal increased significantly when spacers of 36 and 34 residues separated the leucine zipper and the haptoEGFP moieties, whereas the signal decreased when linkers comprised of 46 and 44 amino acids were introduced (Figure 2A ). To extend further this aspect of the study, cells were co-transfected with constructs encoding mismatched linkers to investigate the effect of linker length compatibility on subsequent fluorophore formation. Combination of a short N-terminal haptoEGFP linker with a long C-terminal linker was well tolerated, although at the extremes a decrease in signal was observed when N 157 (6)zip and zip(44)C 158 were co-expressed ( Figure 2B ). Interestingly, the converse combinations showed different results, with specific associations only being detected when zip(4)C 158 was expressed with either N 157 (6)zip (Figures 2A-2C ) or N 157 (16)zip ( Figure 2C ). In all other cases, no fluorescent signal was detected.
Identification of the subcellular site of MV-F and MV-H glycoprotein oligomerization
Considering the results obtained using constructs expressing haptoEGFPs linked to leucine zippers with various spacer lengths, we decided to use hydrophilic spacers of 16 amino acids to separate the glycoproteins from the EGFP fragments. As H glycoprotein is a homodimerizing type II membrane glycoprotein it was not possible to use the 172/173 split point in EGFP, which gave rise to highest level of fluorescence with the leucine zippers, as the H protein must be linked to the new (C -) and endogenous (C-) termini of the haptoEGFP fragments. Therefore the 157/158 split point was chosen, as in this case both the haptoEGFP fusion termini are at the same end of the β-can structure. Two constructs were generated which expressed N 157 (16)MV-H and C 158 (14)MV-H. Expression of the chimaeric proteins was detected by immunoblotting cell lysates using peptide antiserum raised against EGFP ( Figure 3A ). This demonstrated that the haptoEGFP-tagged H glycoproteins were expressed in the transfected cells. Furthermore, the electrophoretic mobility of the chimaeric proteins suggested that they were correctly glycosylated. Fluorescence was readily detected in living cells by CLSM (Figures 4A-4C ). Note that this was a transient transfection, thus not all cells are transfected and consequently the majority of these are non-fluorescent. When pzip(14)C 158 was used in place of pCG-C 158 (14)MV-H, no fluorescence was observed, which demonstrated that the association of the haptoEGFPs was specifically driven only by the dimerization of the H glycoproteins (Supplementary Figure S3 at http://www.bioscirep.org/bsr/032/bsr0320333add.htm). Fluorescence was absent from the nucleus, but was clearly demonstrable from the ER through the Golgi apparatus to the plasma membrane of the cells at higher magnifications ( Figure 4L ). Similar subcellular fluorescent localization was also obtained in living cells transfected with pMV-F(16)N 157 and pMV-F(14)C 158 constructs which express MV-F-haptoEGFP chimaeras. These were expressed, as shown by Western blotting ( Figure 3B ), and the estimated molecular masses were appropriate for glycosylated F-haptoEGFP chimaeras. Of note is the presence of minor bands ( Figure 3B, lane 3) at the estimated molecular mass for N 157 and C 158 haptoEGFPs in blots of cells expressing pMV-F(16)N 157 and pMV-F(14)C 158 , suggestive of a processing event at the C-terminal cytoplasmic tail of the MV-F glycoprotein. This observation is in agreement with previous reports that one in three MV-F proteins is cleaved proximal to the membrane and that this partial cleavage of the trimeric F glycoprotein is a crucial processing event for fusion pore formation [31] .
Addition of haptoEGFP fragments to MV-H and MV-F glycoproteins does not impair their biological activity and allows visualization of F-H association
Multi-nucleated syncytia may be formed either by MV infection or transfection with plasmids encoding the MV-F and MV-H glycoproteins [26, 32] . For effective cell fusion, both glycoproteins must be correctly glycosylated, be trafficked to the cell surface and associate to form a biologically active fusion complex. Thus we reasoned that these constraints would permit the stringent evaluation of EGFP BiFC in this system.
In order to ascertain that the haptoEGFP-tagged glycoproteins were capable of forming a biologically active complex at the cell membrane, cells were transfected with constructs expressing a number of different H and F glycoprotein chimaeras. First, the bioactivity of the H glycoprotein chimaeras was investigated by co-transfection with a plasmid expressing the unmodified F glycoprotein. Initially cell-cell fusion was readily detected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 4
Live-cell UV and CSLM images discernible by phase-contrast microscopy ( Figure 4D ). Fluorescence was detected by vital confocal laser microscopy in all syncytia ( Figures 4E and 4F ), although their size was slightly smaller than syncytia obtained by co-expression of unmodified MV-F and H glycoproteins (results not shown). Cell-cell fusion was detected over large areas of the monolayer by 3 d.p.t. and many syncytia comprised over 200 individual cells. CLSM was used to determine whether it was possible to localize fluorescence within the syncytia and a series of images were collected every 0.35 μm through 13.75 μm of living unfixed cells (one of which is shown in Figure 4G ). When the plasma membrane was examined in x/z and y/z planes, it was difficult to detect a discrete line of fluorescence in single sections. However, small 1-5 μm vesicles were frequently detected at the cell surface (e.g. at the crosswires of Figures 4G-4J ). When these were sectioned, fluorescence appeared to localize in the plasma membrane ( Figure 4N ). In order to visualize these more clearly, confocal datasets were rendered into a three-dimensional model; the surface of a syncytium is shown in Figure 4 (J) (A and Btypical vesicles). These fluorescence images show the spherical nature of these vesicles, and the presence of dimerized glycoproteins in their membrane is also shown in the accompanying movie of this rendered surface (Supplementary Movie S1 at http://www.bioscirep.org/bsr/032/bsr0320333add.htm), from which Figure 4 (J) was constructed from the two sequential frames. These vesicles are reminiscent of budding virions, although they are approximately ten times larger than MV virions. Co-transfected cells were fixed and syncytia were observed at higher magnifications by CLSM to examine the intracellular localization of oligomerized glycoproteins. Fluorescence was detected in the perinuclear regions and also in the honeycomb lattice of the ER and Golgi apparatus ( Figures 4K and 4L) . Interestingly, areas of localized punctate fluorescence were also detected at the periphery of syncytia where the fused cells contact those surrounding the syncytium (Figure 4M , arrows). This shows that the H glycoprotein dimers are not evenly distributed across the cell surface. These local accumulations could be sites of fusion pore formation where the H glycoproteins are in close contact with the cellular receptor, in this case CD46. The extracellular localization of the H glycoprotein dimers on the surface of unpermeabilized cells was examined by indirect immunofluorescence using an anti-H glycoprotein monoclonal antibody, which binds to the ectodomain. A significant percentage of dimeric Htrimeric F glycoprotein complexes were detected, indicating that these were correctly folded, processed and trafficked to the cell membrane ( Figures 4N and 4P) where, in view of the size of the syncytia, they were clearly biologically active. In complementary experiments, retention of bioactivity was also confirmed in cells expressing the MV-F (16) (16) MV-H chimaera pair. Fluorescent syncytia were observed in both cases and the appropriate controls demonstrated that these were specific interactions (Table 1) .
Fluorimetery was used to determine whether the microscopically visible fluorescence of individual cells and syncytia could be quantified for a whole population of transfected cells. Cells were transfected and cultured for 48 h before quantification to allow accumulation of tagged F and H glycoproteins. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
DISCUSSION
Originally, BiFC using GFP was demonstrated in prokaryotes using high-affinity leucine zippers [18] . More recently, the same laboratory reported its application to lower affinity interactions with K d values in the millimolar range [33] . The technology was shown to be effective in eukaryotic cells [19, 20, 34] and in a modified form, which takes advantage of self-splicing proteins or inteins, has been used to examine the interaction of helixloop-helix proteins in vivo in a murine model [35] . Studies in plants have demonstrated that orientation of the fusion termini of interacting partners is important when these are embedded in subcellular organelles [36, 37] .
We have used BiFC to determine where both type I and II transmembrane glycoprotein oligomerization events occur within eukaryotic cells using the MV-F fusion and the MV-H-receptorbinding glycoproteins as a model. These proteins were selected as it is known that they both homo-olgiomerize and heterooligomerize with each other. Importantly, they are both predicted to have a cytoplasmic tail to facilitate the interaction of the EGFP fragments [12] . In addition, we have also reported the detection of oligomerizing glycoproteins at the plasma membrane. Collectively, these results demonstrate that this approach offers a diversity of opportunities for the study of protein-protein interactions in all cellular compartments.
In contrast with our initial anti-parallel leucine zipper studies, where the fusion termini of the interacting partners are likely to be close together (<5Å; 1Å = 0.1 nm), it is thought, although not formally proven, that the cytoplasmic tails of the interacting F and H glycoproteins are also relatively close and are certainly the same side of the plasma membrane following insertion. In the initial studies, the single helix of each leucine zipper when associated adopts an anti-parallel coiled-coil orientation to the other. Thus in these experiments the fusion points are close in space and may be readily accommodated at a variety of positions around the EGFP molecule, including both novel (N -and C -) and the native (N-and C-) termini. In contrast, for the membrane bound MV-H glycoprotein homo-dimerization studies, where the fusions were exclusively to the cytoplasmic N-terminus of MV-H molecules, we were forced to use the C-and C -termini of the haptoEGFP moieties. This directed us to use the original 157/158 split point proposed by Ghosh et al. [18] , which is adjacent to the native C-terminus of the properly folded EGFP, despite the higher fluorescence we had obtained with the 172/173 split point with the leucine zippers, as this could have necessitated an imbalance in the linker length due to the separation of the two fusion termini in the assembled EGFP molecule, thus potentially leading to loss of fluorescence (see Figure 2C) . Furthermore, split points at neighbouring positions, 154/155 [19, 20] and 158/159 [21] in the same loop between sheets 7 and 8, have been shown to be useful.
The observation that up to 46 residues (which equates to more than 170Å for each linker in an extended conformation) may be inserted into the linker sequence between the binding partner and the reporting haptoEGFP is important for studies which examine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . proteins whose N-or C-termini are relatively far apart, thereby possibly limiting effective haptoEGFP association. In summary, our results with the leucine zippers highlight the flexibility of the system to accurately report protein-protein interactions in living eukaryotic cells and suggest that the spatial proximity of the N-and C-termini of the interacting protein should not place a significant restriction on the association of the haptoEGFPs, provided sufficiently long spacers are included and that the fusion termini of the interacting partners are not physically separated by a membrane. The use of such long linkers has not been used in any published BiFC system to date. A combined splitRenilla luciferase/haptoEGFP approach has been used to study small-molecule-mediated hetero-dimerization [38] . In that study, signals were shown to increase when the spacers were comprised of two or four EAAAR repeats.
It has been suggested that over one-third of all cellular proteins are anchored in the lipid bilayer [39] and, as such, are inaccessible to direct visualization by reporter systems, such as yeast two-hybrid, which requires that the interacting partners can translocate to the nucleus [1] . Thus a variety of alternative approaches, such as the reverse Ras recruitment system [40] , inactivation of a G-protein signalling pathway [41] and the split ubiquitin system [6] , have been used to examine the interaction of membrane proteins. Although the leucine zippers have high affinity and proximal N-and C-termini, this will clearly not be the case for all interacting protein partners. This is particularly clear if type I or type II membrane glycoprotein interactions are considered as, in these cases, the N-and C-termini of the membrane-spanning glycoprotein occupy mutually inaccessible intra-and extra-cellular cytoplasmic spaces. The fact that BiFC is capable of specifically reporting interactions of ER-targeted glycoproteins of unknown structure attests to its considerable robustness and flexibility. In these experiments, the lack of retention of the chimaeras in the ER, together with the demonstration that both type I and type II MV glycoproteins fold correctly, can dimerize, reach the cell membrane and retain both immunoreactivity and biological function in a fusion active complex, illustrates the general utility of this approach, which derives in part from the inertness of the haptoEGFP fragments. This is particularly relevant for the MV-H-haptoEGFP constructs as the EGFP sequences are at the N-terminus in these fusions, which is known to direct the glycoprotein to the ER. The fact that a pattern of fluorescence characteristic of ER distribution was observed with the both the MV-H-and MV-F-haptoEGFP fusion partners (shown for MV-H in Figure 4L ) indicates that oligomerization of MV glycoproteins occurs in this subcellular compartment. This is the first direct demonstration of this phenomenon. Our results with the viral glycoproteins demonstrate that fluorescence complementation can be used to monitor protein interactions throughout the cell, particularly in the context of the plasma membrane, and that high-affinity binding is not obligatory for effective fluorescence complementation. Most importantly, we report an in vitro system which provides a stringent demonstration of the biological inertness of the haptoEGFP methodology. In order for syncytia to be generated, both MV-H and MV-F glycoproteins must be correctly glycosylated, be trafficked to the cell surface and associate to form a fusion active complex. In this context, our observation of large syncytia formation when any of the viral glycoprotein chimaeras are co-transfected into mammalian cells attests to the retention of biological function by the modified membrane proteins and that all of the syncytia were fluorescent indicates that the glycoprotein association effectively drives fluorophore generation for both homologous and heterologous interactions. The robustness and versatility of this method demonstrates that it should be generally applicable and that it could be adapted to library screening for binding interactions.
A number of opportunities exist to extend this system and we are currently developing a panning-based approach to enable the detection of unidentified binding partners. This has been possible using a protein splicing approach [42] . This offers the possibility to screen a library of haptoEGFP-conjugated proteins in living cells by detection of fluorescence. Single-cell PCR and sequencing approaches can be readily applied to isolated cells and this will be used to identify unknown binding partners. We have shown that it is possible to generate recombinant MVs which express whole EGFP as an additional protein [30] . At present we are attempting to recover a recombinant virus which expresses separate H glycoproteins fused to haptoEGFPs. If this is possible, it will give us the opportunity to examine glycoprotein oligomerization in the context of an actual virus infection.
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